• Abizaid A (2007) Sirolimus-eluting coronary stents: a review. Vasc Health Risk Manag 3(2):191–201. https://doi.org/10.2147/vhrm.2007.3.2.191

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Abizaid A, Costa MA, Blanchard D, Albertal M, Eltchaninoff H et al (2004) Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL trial. Eur Heart J 25(2):107–112. https://doi.org/10.1016/j.ehj.2003.11.002

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Aboyans V, Ricco JB, MEL B, Björck M, Brodmann M et al (2018) 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European stroke organization (ESO) the task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 39(9):763–816. https://doi.org/10.1093/eurheartj/ehx095

    Article 
    PubMed 

    Google Scholar
     

  • Ali RM, Abdul Kader MASK, Wan Ahmad WA, Ong TK, Liew HB et al (2019) Treatment of coronary drug-eluting stent restenosis by a Sirolimus- or paclitaxel-coated balloon. JACC Cardiovasc Interv 12(6):558–566. https://doi.org/10.1016/j.jcin.2018.11.040

    Article 
    PubMed 

    Google Scholar
     

  • Biondi-Zoccai GG, Sangiorgi G, Lotrionte M, Feiring A, Commeau P et al (2009) Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther 16(3):251–260. https://doi.org/10.1583/09-2691.1

    Article 
    PubMed 

    Google Scholar
     

  • Böhme T, Noory E, Beschorner U, Macharzina R, Zeller T (2021) The SELUTION SLR™ drug-eluting balloon system for the treatment of symptomatic femoropopliteal lesions. Futur Cardiol 17(2):257–267. https://doi.org/10.2217/fca-2020-0085

    CAS 
    Article 

    Google Scholar
     

  • Braga SF, Neves JR, Ferreira J, Carrilho C, Simões JC et al (2019) Neointimal hyperplasia. Rev Port Cir Cardiotorac Vasc 26(3):213–217

    PubMed 

    Google Scholar
     

  • Caradu C, Lakhlifi E, Colacchio EC, Midy D, Bérard X et al (2019) Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease. J Vasc Surg 70(3):981–995.e10. https://doi.org/10.1016/j.jvs.2019.01.080

    Article 
    PubMed 

    Google Scholar
     

  • Conte MS, Bradbury AW, Kolh P, White JV, Dick F et al (2019) Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS), European Society for Vascular Surgery (ESVS), and world Federation of Vascular Societies (WFVS). Global vascular guidelines on the Management of Chronic Limb-Threatening Ischemia. Eur J Vasc Endovasc Surg 58(1S):S1–S109.e33. https://doi.org/10.1016/j.ejvs.2019.05.006

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Dani S, Shah D, Sojitra P, Parikh K, Shetty R et al (2019) A novel nanocarrier sirolimus-coated balloon for coronary interventions: 12-month data from the Nanoluté registry. Cardiovasc Revasc Med 20(3):235–240. https://doi.org/10.1016/j.carrev.2018.06.003

    Article 
    PubMed 

    Google Scholar
     

  • Fanelli F, Cannavale A, Gazzetti M, Lucatelli P, Wlderk A, Cirelli C, d’Adamo A, Salvatori FM (2014) Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease. Cardiovasc Intervent Radiol 37(4):898–907. https://doi.org/10.1007/s00270-014-0904-3

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Feldman DN, Armstrong EJ, Aronow HD, Gigliotti OS, Jaff MR, Klein AJ, Parikh SA, Prasad A, Rosenfield K, Shishehbor MH, Swaminathan RV, White CJ (2018) SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions. Catheter Cardiovasc Interv 92(1):124–140. https://doi.org/10.1002/ccd.27635

    Article 
    PubMed 

    Google Scholar
     

  • Global burden of disease study 2013 collaborators (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 386(9995):743–800. https://doi.org/10.1016/S0140-6736(15)60692-4

    Article 
    PubMed Central 

    Google Scholar
     

  • Hirsch AT, Haskal ZJ, Hertzer NR et al (2006) ACC/AHA guidelines for the Management of Patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American associations for vascular surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA task force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)–summary of recommendations. J Vasc Interv Radiol 17(9):1383–1397quiz 1398. https://doi.org/10.1097/01.RVI.0000240426.53079.46

    Article 
    PubMed 

    Google Scholar
     

  • Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Karnabatidis D (2018) Risk of death following application of paclitaxel-coated balloons and stents in the Femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 7(24):e011245. https://doi.org/10.1161/JAHA.118.011245

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Paraskevopoulos I et al (2020) Risk of death and amputation with use of paclitaxel-coated balloons in the Infrapopliteal arteries for treatment of critical limb ischemia: a systematic review and meta-analysis of randomized controlled trials. J Vasc Interv Radiol 31(2):202–212. https://doi.org/10.1016/j.jvir.2019.11.015

    Article 
    PubMed 

    Google Scholar
     

  • Kullo IJ, Rooke TW (2016) Clinical practice. Peripheral artery disease. N Engl J Med 374(9):861–871. https://doi.org/10.1056/NEJMcp1507631

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Lemos PA, Farooq V, Takimura CK, Gutierrez PS, Virmani R et al (2013) Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter. EuroIntervention. 9(1):148–156. https://doi.org/10.4244/EIJV9I1A21

    Article 
    PubMed 

    Google Scholar
     

  • Lin JH, Brunson A, Romano PS, Mell MW, Humphries MD (2019) Endovascular-first treatment is associated with improved amputation-free survival in patients with critical limb ischemia. Circ Cardiovasc Qual Outcomes 12(8):e005273. https://doi.org/10.1161/CIRCOUTCOMES.118.005273

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mayfield JA, Reiber GE, Maynard C, Czerniecki JM, Caps MT et al (2001) Survival following lower-limb amputation in a veteran population. J Rehabil Res Dev 38(3):341–345

    CAS 
    PubMed 

    Google Scholar
     

  • Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA et al (2007) Inter-society consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45 Suppl S:S5–S67. https://doi.org/10.1016/j.jvs.2006.12.037

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Reinecke H, Unrath M, Freisinger E, Bunzemeier H, Meyborg M et al (2015) Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J 36(15):932–938. https://doi.org/10.1093/eurheartj/ehv006

    Article 
    PubMed 

    Google Scholar
     

  • Salisbury AC, Li H, Vilain KR, Jaff MR, Schneider PA et al (2016) Cost-effectiveness of endovascular Femoropopliteal intervention using drug-coated balloons versus standard percutaneous Transluminal angioplasty: results from the IN.PACT SFA II trial. JACC Cardiovasc Interv 9(22):2343–2352. https://doi.org/10.1016/j.jcin.2016.08.036

    Article 
    PubMed 

    Google Scholar
     

  • Sehgal SN (2003) Sirolimus: its discovery, biological properties, and mechanism of action. Transplant Proc 35(3 Suppl):7S–14S. https://doi.org/10.1016/s0041-1345(03)00211-2

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • Soon SXY, Yap CJQ, Lee SQW, Yap HY, Chong TT et al (2020) Re: risk of death and amputation with use of paclitaxel-coated balloons in the Infrapopliteal arteries for treatment of critical limb ischemia: a systematic review and meta-analysis of randomized controlled trials. J Vasc Interv Radiol 31(6):1029–1030. https://doi.org/10.1016/j.jvir.2020.02.031

    Article 
    PubMed 

    Google Scholar
     

  • Soon SXY, Patel A, Chong TT, Yap CJQ, Tay HT, Tay KH, Sivanathan C, Tang TY (2021) Distribution of peripheral arterial disease in patients undergoing endovascular revascularization for chronic limb threatening Ischaemia: insights from the vascular quality initiative in Singapore. Vasc Specialist Int 37:13. https://doi.org/10.5758/vsi.210016

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tan CW, Tan RY, Pang SC, Tng ARK, Tang TY, Zhuang KD, Chua JME, Tay KH, Chong TT, Tan CS (2021a) Single-center prospective pilot study of Sirolimus drug-coated balloon angioplasty in maintaining the patency of Thrombosed Arteriovenous graft. J Vasc Interv Radiol 32(3):369–375. https://doi.org/10.1016/j.jvir.2020.11.010

    Article 
    PubMed 

    Google Scholar
     

  • Tan RY, Pang SC, Tng ARK, Tan CS (2021b) Paclitaxel-coated balloon angioplasty for recurrent arteriovenous fistula stenosis. Kidney Int 100(2):480–481. https://doi.org/10.1016/j.kint.2021.04.041

    Article 
    PubMed 

    Google Scholar
     

  • Taneva GT, Pitoulias GA, Abu Bakr N, Kazemtash M, Muñoz Castellanos J, Donas KP (2022) Assessment of Sirolimus- vs. paCLitaxEl-coated balloon angioPlasty in atherosclerotic femoropopliteal lesiOnS (ASCLEPIOS study): preliminary results. J Cardiovasc Surg 63(1):8–12. https://doi.org/10.23736/S0021-9509.21.12169-X

    Article 

    Google Scholar
     

  • Tang TY, Choke EC, Walsh SR, Tiwari A, Chong TT (2020a) What now for the endovascular community after the paclitaxel mortality meta-analysis: can Sirolimus replace paclitaxel in the peripheral vasculature? J Endovasc Ther 27(1):153–156. https://doi.org/10.1177/1526602819881156

    Article 
    PubMed 

    Google Scholar
     

  • Tang TY, Soon SXY, Yap CJQ, Chan SL, Tan RY, Pang SC, Lee SQW, Yap HY, Choke ETC, Tan CS, Chong TT (2020b) Early (6 months) results of a pilot prospective study to investigate the efficacy and safety of sirolimus coated balloon angioplasty for dysfunctional arterio-venous fistulas: MAgicTouch intervention leap for dialysis access (MATILDA) trial. PLoS One 15(10):e0241321. https://doi.org/10.1371/journal.pone.0241321

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tang TY, Soon SXY, Yap CJQ, Chan SL, Choke ETC, Chong TT (2021c) Utility of Sirolimus coated balloons for salvaging dysfunctional Arteriovenous fistulae: one year results from the MATILDA trial. Eur J Vasc Endovasc Surg 62(2):316–317. https://doi.org/10.1016/j.ejvs.2021.04.014

    Article 
    PubMed 

    Google Scholar
     

  • Tang TY, Yap C, Soon SXY, Chan SL, Lee QS et al (2021a) World’s first experience treating TASC II C and D Tibial occlusive disease using the Selution SLR Sirolimus-eluting balloon: six-month results from the PRESTIGE study. J Endovasc Ther 28(4):555–566. https://doi.org/10.1177/15266028211007457

    Article 
    PubMed 

    Google Scholar
     

  • Tang TY, Sulaiman MSB, Soon SXY, Yap CJQ, Patel A, Chong TT (2022b) Slow-flow phenomena following lower limb paclitaxel- and sirolimus-coated balloon angioplasty in the setting of chronic limb threatening ischaemia-a case series. Quant Imaging Med Surg 12(3):2058–2065. https://doi.org/10.21037/qims-21-633

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tang TY, Yap CJ, Soon SX, Tan RY, Pang SC, Patel A, Gogna A, Tan CS, Chong TT (2022a) Utility of the selution SLR™ sirolimus eluting balloon to rescue failing arterio-venous fistulas – 12 month results of the ISABELLA registry from Singapore. CVIR Endovasc 5(1):8. https://doi.org/10.1186/s42155-022-00287-1

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Teichgräber U, Ingwersen M, Platzer S, Lehmann T, Zeller T, Aschenbach R, Scheinert D (2021) Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial. Trials. 22(1):665. https://doi.org/10.1186/s13063-021-05631-9

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Torii S, Yahagi K, Mori H, Harari E, Romero ME, Kolodgie FD, Young B, Ragheb A, Virmani R, Finn AV (2018) Biologic drug effect and particulate embolization of drug-eluting stents versus drug-coated balloons in healthy swine Femoropopliteal arteries. J Vasc Interv Radiol 29(7):1041–1049.e3. https://doi.org/10.1016/j.jvir.2018.02.006

    Article 
    PubMed 

    Google Scholar
     

  • Varetto G, Gibello L, Boero M, Frola E, Peretti T et al (2019) Angioplasty or bare metal stent versus drug-eluting endovascular treatment in femoropopliteal artery disease: a systematic review and meta-analysis. J Cardiovasc Surg 60(5):546–556. https://doi.org/10.23736/S0021-9509.19.11115-9

    Article 

    Google Scholar
     

  • Zeller T, Brechtel K, Meyer DR, Noory E, Beschorner U et al (2020) Six-month outcomes from the first-in-human, single-arm SELUTION sustained-Limus-release drug-eluting balloon trial in Femoropopliteal lesions. J Endovasc Ther 27(5):683–690. https://doi.org/10.1177/1526602820941811

    Article 
    PubMed 

    Google Scholar
     

  • Choke E, Tang TY, Peh E, Damodharan K, Cheng SC et al (2021) MagicTouch PTA Sirolimus coated balloon for Femoropopliteal and below the knee disease: results from XTOSI pilot study up to 12 months. J Endovasc Ther 15266028211064816. https://doi.org/10.1177/15266028211064816

  • LIFE-BTK Randomized Controlled Trial (LIFE-BTK). 2020. https://clinicaltrials.gov/ct2/show/NCT04227899. Assessed 22 Jan 2022

  • MDK-1901 Clinical Study. https://rctportal.niph.go.jp/en/detail?trial_id=JapicCTI-205434. Assessed 22 Jan 2022

  • Med Alliance’s SELUTION FIM study achieves primary endpoint. 2018. https://evtoday.com/2018/01/31/med-alliances-selution-fim-study-achieves-primary-endpoint. Accessed 16 Jan 2022

  • SAVE Trial – Use of the Selution Sirolimus Eluting Balloon for Dysfunctional AV accEss Treatment Indications (SAVE).https://clinicaltrials.gov/ct2/show/NCT04327609. Assessed 22 Jan 2022

  • Sirolimus Coated Angioplasty Versus Plain Balloon Angioplasty (IMPRESSION). https://clinicaltrials.gov/ct2/show/NCT04409912. Assessed 22 Jan 2022

  • Tang TY, Soon SX, Yap CJ, Tan RY, Pang SC, Patel A, Gogna A, Tan CS, Chong TT (2021b) Endovascular salvage of failing arterio-venous fistulas utilising sirolimus eluting balloons: six months results from the ISABELLA trial. J Vasc Access 11297298211067059. https://doi.org/10.1177/11297298211067059

  • Tang TY, Sulaiman MSB, Soon SXY, Yap CJQ, Patel A, Chong TT (2021d) Slow-flow phenomena following lower limb paclitaxel- and sirolimus-coated balloon angioplasty in the setting of chronic limb threatening ischaemia—a case series. Quant Imaging Med Surg. https://doi.org/10.21037/qims-21-633

  • Update: Treatment of peripheral arterial disease with paclitaxel-coated balloons and paclitaxeleluting stents potentially associated with increased mortality—letter to health care providers. 2019. Available at https://www.fda.gov/medical-devices/letters-health-care-providers/august-7-2019-update-treatment-peripheral-arterial-diseasepaclitaxel-coated-balloons-and-paclitaxel. Accessed 14 Jan 2022

  • Rights and permissions

    Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

    Disclaimer:

    This article is autogenerated using RSS feeds and has not been created or edited by OA JF.

    Click here for Source link (https://www.springeropen.com/)